Question 1

Does Bahl & Gaynor own WST stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Bahl & Gaynor holds 2,025 shares of WST (West Pharmaceutical Services), worth $750,789.

Question 2

How many shares of WST does Bahl & Gaynor own?

Accepted Answer

As of its Q3 2026 13F, Bahl & Gaynor holds 2,025 shares of WST (West Pharmaceutical Services).

Question 3

What is Bahl & Gaynor's WST position worth?

Accepted Answer

As of its Q3 2026 13F, Bahl & Gaynor's WST position is worth $750,789.

Question 4

When did Bahl & Gaynor first buy WST?

Accepted Answer

Bahl & Gaynor already held WST in its Q1 2019 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Unchanged	2,025	0.0%	$750,789	0.0%	$370.76	0
2026-Q2	Decreased	2,025	-4.7%	$726,975	0.0%	$358.77	0
2026-Q1	Unchanged	2,125	0.0%	$532,610	0.0%	$250.29	0
2025-Q4	Unchanged	2,125	0.0%	$584,673	0.0%	$274.50	0
2025-Q3	Unchanged	2,125	0.0%	$557,451	0.0%	$261.51	0
2025-Q2	Decreased	2,125	-8.6%	$464,950	0.0%	$217.94	0
2025-Q1	Decreased	2,325	-46.7%	$520,521	0.0%	$222.78	0
2024-Q4	Decreased	4,364	-8.4%	$1.4M	0.0%	$325.74	0
2024-Q3	Increased	4,767	+10.2%	$1.4M	0.0%	$298.30	28